• Exchange: Natl India
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

HKCI:IN

626.70 INR 4.20 0.67%

As of 02:19:44 ET on 07/23/2014.

Snapshot for Hikal Ltd (HKCI)

Open: 634.35 Day's Range: 626.00 - 638.85 Volume: 2,333
Previous Close: 630.90 52wk Range: 380.30 - 673.00 1-Yr Rtn: +60.89%

Stock Chart for HKCI

No chart data available.
  • HKCI:IN 626.65
  • 1D
  • 1M
  • 1Y
630.90
Interactive HKCI Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for HKCI

Current P/E Ratio (ttm) 16.2310
Estimated P/E(03/2015) -
Relative P/E vs. SENSEX 0.8739
Earnings Per Share (INR) (ttm) 38.8700
Est. EPS (INR) (03/2015) -
Est. PEG Ratio -
Market Cap (M INR) 10,372.06
Shares Outstanding (M) 16.44
30 Day Average Volume 69,204
Price/Book (mrq) 2.0414
Price/Sale (ttm) 1.2425
Dividend Indicated Gross Yield 0.71%
Cash Dividend (INR) 4.5000
Dividend Ex-Date
5 Year Dividend Growth 2.38%
Next Earnings Announcement 05/06/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for HKCI

  • Revenue
  • Net Income (M/INR)
  • Profit Margin (%)

Company Profile & Key Executives for HKCI

Hikal Limited specializes in the custom synthesis and contract manufacture of pharmaceuticals, agrochemicals and intermediates. The Group has relationships with a number of companies, including the Sumitomo Corporation, AgrEvo, Merck and Novartis.

Jai V HiremathChairman/Joint Mng Dir/FounderSameer HiremathPresident/Joint Mng Dir
Ashok AnandPresident:PharmaceuticalsPeter NightingalePresident:Acoris Research
More Company Profile & Key Executives for HKCI

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil